Journal of IMAB - Annual Proceeding (Scientific Papers) · Published 2026-07-13 · DOI 10.5272/jimab.2026323.6971
Zlatina Ivanova, Nikolay Kyuchukov, Yavor Ivanov
The Covid-19 pandemic passed several years ago, but a significant proportion of people still suffer its consequences. Physicians face the difficult task of managing these consequences, monitoring their patients over time, and the need to apply an individual-specific approach. In this article, the main risk factor and mechanisms for developing post-COVID fibrosis are discussed. The available therapeutic options for preventing and treating of that type of fibrosis are summarized. The need for follow-up of these patients is emphasized. Basic guidelines and optimal time intervals for their follow-up are presented.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Ivanova, Z., Kyuchukov, N., Ivanov, Y. (2026). PULMONARY FIBROSIS AFTER COVID-19 – RISK FACTORS, MECHANISMS, THERAPEUTIC OPTIONS AND FOLLOW-UP. Journal of IMAB - Annual Proceeding (Scientific Papers). https://doi.org/10.5272/jimab.2026323.6971